Oxycare 3.6% W/W Cutaneous Spray Solution
Revised: July 2010
ATCVet code amended
SUMMARY OF PRODUCT CHARACTERISTICS
1. Name of the veterinary medicinal product
Oxycare 3.6 %w/w Cutanous Spray Solution
2. Qualitative and quantitative composition
Active Substance:
Each 140g aerosol can contain’s:
5g Oxytetracycline Hydrochloride 3.6% w/w
Excipients:
Patent Blue V (E 131) 0.33% w/w as a marker dye
For a full list of excipients, see section 6.1
3. Pharmaceutical form
Cutaneous spray solution
A blue opaque solution
4. Clinical Particulars
4.1 Target species
Cattle, sheep and pigs
4.2 Indications for use, specifying the target species
Oxycare Aerosol is indicated for the treatment of foot rot in sheep and topical infections caused by organisms sensitive to oxytetracycline in cattle, sheep and pigs.
4.3 Contraindications
None
4.4 Special Warnings for each target species
None
4.5 Special precautions for use
Special precautions for use in animals
For external use only
Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possiable, thearpy should be based on local (regional, farm level) epidermiological information about susceptibility of the target bacteria.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
Keep away from eyes.
Avoid contact with skin.
Avoid inhaling vapours.
Wash hands after use.
Do not spray on a naked flame or any incandescent material.
Highly flammable
Must be used in a well ventilated area
Do not smoke when using this product.
4.6 Adverse reactions (frequency and seriousness)
None
4.7 Use during pregnancy, lactation or lay
The product can be safely administered to pregnant and lactating animals.
4.8 Interaction with other medicinal products and other forms of interaction
None
4.9 Amounts to be administered and administration route
For the treatment of foot rot, the hooves should be cleaned and pared prior to administration. Wounds should be cleaned prior to administration. Shake the can before use. Spray for a few seconds or until the lesion is adequately covered
Treated sheep should be allowed to stand on dry ground for one hour before returning to pasture.
Overdose (symptoms, emergency procedures, antidotes), if necessary
Not applicable.
Withdrawal period
Meat –Zero days
Milk – Zero hours
5. pharmacological properties
Pharmacotherapeutic group: Antibiotics and chemotherapeutics for dermatological use, Antibiotics for topical use, Tetracycline and derivatives
ATC Vet Code: QD06AA03
5.1 Pharmacodynamic properties
Oxytetracycline is a bacteriostatic antibiotic that inhibits protein synthesis in a wide range of susceptible bacteria. Inside the cell it binds irreversibly to receptors on the 30S subunit of the bacterial ribosome where it interferes with the binding of the aminoacyl-transfer RNA to the acceptor site on the messenger RNA ribosome complex. This effectively prevents the addition of amino acids to the elongating peptide chain, inhibiting protein synthesis.
6. Pharmaceutical particulars
6.1 List of excipients
Patent Blue V (E131),
Magnesium Chloride Hexahydrate,
Povidone K17,
Propylene Glycol,
Ethanolamine (for pH adjustment),
Methanol/ Isopropyl Alcohol,
Water Purified.
6.2 Incompatibilities
None Known
Shelf life
Shelf life of the veterinary medicinal product as packaged for sale: 2 years.
Special precautions for storage
Pressurised container, protect from sunlight and do not expose to temperatures above 50°C.
Do not pierce or burn, even after use.
Do not store above 25ºC.
Nature and composition of immediate packaging
Aluminium cans containing 140g of product with valves caps and actuators.
Aerosol bag on valve assembly, capable of delievering 10g to 15g of product per 5 seconds
The propellant is Nitrogen (oxygen-free).
Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products
Any unused veterinary medicinal product or waste materials derived from such veterianry medicinal products should be disposed of in accordance with local requirements.
7. MARKETING AUTHORISATION HOLDER
Norbrook Laboratories Limited
Station Works
NEWRY
Northern Ireland
BT35 6JP
8. MARKETING AUTHORISATION NUMBER(S)
Vm: 02000/4164
DATE OF FIRST AUTHORISATION
30th March 1998
10. DATE OF REVISION OF THE TEXT
July 2010
4